作者: inhibit 時(shí)間: 2025-3-21 23:40 作者: manifestation 時(shí)間: 2025-3-22 00:38
Disordered Immunological Function,my, and transplantation are routinely performed for the treatment of primary and metastatic liver tumors with minimal morbidity and mortality. Since accurate diagnosis remains the key to clinical and surgical management, the emphasis of this chapter is on classification, morphological features and d作者: Pert敏捷 時(shí)間: 2025-3-22 07:46
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies,pensated cirrhosis. There is not even level one evidence to guide the choice of modality to be used in individual cases and treatment algorithms vary widely among high volume centres. Newer and emerging techniques and approaches such as laparoscopic liver resection and living donor transplantation c作者: Distribution 時(shí)間: 2025-3-22 11:10
Pathologic Features of Primary and Metastatic Hepatic Malignancies,my, and transplantation are routinely performed for the treatment of primary and metastatic liver tumors with minimal morbidity and mortality. Since accurate diagnosis remains the key to clinical and surgical management, the emphasis of this chapter is on classification, morphological features and d作者: entail 時(shí)間: 2025-3-22 13:56
0927-3042 e significance of the Ras superfamily of GTPases. It will be of benefit to all surgeons, oncologists and other specialists who treat these malignancies, as well as to trainees looking to increase their understanding of the field..978-3-319-81712-5978-3-319-34244-3Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: entail 時(shí)間: 2025-3-22 17:42
Flavio Ruffinatto,Alan Crivellarohe adverse side effects attributable to a lack of cell specificity associated with traditional chemotherapy. Here we aim to describe the current state of understanding regarding the genetic related causes of cancers, the targeted therapies aimed at killing them and the inter-relationship between these two.作者: Perennial長(zhǎng)期的 時(shí)間: 2025-3-22 23:16 作者: 努力趕上 時(shí)間: 2025-3-23 03:53
Continuously Variable Endoscopy, discusses the treatment for gastrointestinal stromal tumors (GIST), and small bowel tumors. In addition to systemic therapies, this chapter explores the surgical management of gastric and small bowel tumors including the extent of the gastric lymph node dissection.作者: Eeg332 時(shí)間: 2025-3-23 07:38
https://doi.org/10.1007/978-3-540-68215-8on of these neoplasms engenders rapid tumor progression, which repeatedly thwarts successful surgical treatment.??This chapter will focus on the pathological features of?malignant neoplasms of the esophagus and stomach.作者: 使顯得不重要 時(shí)間: 2025-3-23 17:10
K. J. Stout,E. J. Davis,P. J. Sullivanll require more objective study of the return on investment for any given treatment modality, and cost-effectiveness analyses will be instrumental in providing solutions to the inequalities in healthcare delivery.作者: 有常識(shí) 時(shí)間: 2025-3-23 18:43 作者: 駁船 時(shí)間: 2025-3-23 22:59
Pathologic Features of Esophageal and Gastric Malignancies,on of these neoplasms engenders rapid tumor progression, which repeatedly thwarts successful surgical treatment.??This chapter will focus on the pathological features of?malignant neoplasms of the esophagus and stomach.作者: lethargy 時(shí)間: 2025-3-24 03:58 作者: HAUNT 時(shí)間: 2025-3-24 08:20
Cost-Effectiveness Analysis in Cancer Care,ll require more objective study of the return on investment for any given treatment modality, and cost-effectiveness analyses will be instrumental in providing solutions to the inequalities in healthcare delivery.作者: Cervical-Spine 時(shí)間: 2025-3-24 14:02 作者: constitute 時(shí)間: 2025-3-24 15:07 作者: Occlusion 時(shí)間: 2025-3-24 20:43 作者: 特征 時(shí)間: 2025-3-25 02:06
Pathologic Features of Miscellaneous Foregut Malignancies,ions to effectively manage and prognosticate the patients in which they occur. In this chapter, we focus on the clinical, morphologic, and genetic features of the primary esophageal and gastric neoplasms of neuroendocrine, mesenchymal, and lymphoid origin.作者: 瑣碎 時(shí)間: 2025-3-25 05:31
Circulating Tumor Cells in Gastrointestinal Cancer: Current Practices and Future Directions,iting new clinical and research applications. In this chapter, we will review the current state of CTC research in GI cancers as well as the potential future applications that are currently being developed.作者: 匍匐前進(jìn) 時(shí)間: 2025-3-25 09:11
Gall Bladder Cancer,neoplasms. Gallbladder cancer spreads early by lymphatic or hematogenous metastasis and by direct invasion into the liver. While surgery may well be curative at early stages, both surgical and nonsurgical treatments remain largely unsuccessful in patients with more advanced disease.作者: Patrimony 時(shí)間: 2025-3-25 14:10 作者: irritation 時(shí)間: 2025-3-25 15:48
Repeat Hepatectomy for Colorectal Liver Metastases,isease to the liver. This chapter discusses the management of patients with recurrent colorectal metastases to the liver after initial resection and offers strategies to optimize and guide their treatment with a multimodality approach.作者: 暴發(fā)戶(hù) 時(shí)間: 2025-3-25 20:31
Robotic Rectal Cancer Surgery,radiation, transanal resection techniques, and minimally invasive surgery. Robotic surgery for the treatment of rectal cancer represents the current pinnacle of minimally invasive technology for this disease process.作者: 季雨 時(shí)間: 2025-3-26 00:15 作者: 難聽(tīng)的聲音 時(shí)間: 2025-3-26 04:51 作者: Fantasy 時(shí)間: 2025-3-26 11:43
The Role of Laser in the Genital Districtneoplasms. Gallbladder cancer spreads early by lymphatic or hematogenous metastasis and by direct invasion into the liver. While surgery may well be curative at early stages, both surgical and nonsurgical treatments remain largely unsuccessful in patients with more advanced disease.作者: Tailor 時(shí)間: 2025-3-26 15:34
Cholestasis and Biliary Obstruction, burden, partial hepatectomy to remove gross metastatic disease will likely become increasingly utilized in the future. This chapter discusses the presentation and clinical factors in liver directed surgical resection.作者: 高歌 時(shí)間: 2025-3-26 18:57 作者: ANTI 時(shí)間: 2025-3-26 21:45 作者: COM 時(shí)間: 2025-3-27 03:01 作者: radiograph 時(shí)間: 2025-3-27 06:11 作者: BOGUS 時(shí)間: 2025-3-27 09:54 作者: Altitude 時(shí)間: 2025-3-27 14:23 作者: Astigmatism 時(shí)間: 2025-3-27 20:20
Gall Bladder Cancer,l. in CA Cancer J Clin 65:5–29, 2015 [.]). This disease’s insidious nature and typically late presentation place it among the most lethal of invasive neoplasms. Gallbladder cancer spreads early by lymphatic or hematogenous metastasis and by direct invasion into the liver. While surgery may well be c作者: 避開(kāi) 時(shí)間: 2025-3-27 23:20
Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma,, hilar, or extrahepatic. Epidemiologic studies suggest that the incidence of intrahepatic CCs may be increasing worldwide. In this chapter, we review the risk factors, clinical presentation, and management of cholangiocarcinoma.作者: 盟軍 時(shí)間: 2025-3-28 05:29
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies,related to chronic hepatitis B and C viral infection. Surgical resection, liver transplantation, and tumour ablation are potentially curative modalities in cases of localized, non-metastatic, hepatocellular carcinoma. Systemic sorafenib has been shown to be marginally effective in slow disease progr作者: GIBE 時(shí)間: 2025-3-28 09:31 作者: 鎮(zhèn)壓 時(shí)間: 2025-3-28 12:04 作者: Infant 時(shí)間: 2025-3-28 17:11 作者: buoyant 時(shí)間: 2025-3-28 21:34
Locoregional Therapies for Primary and Secondary Hepatic Malignancies,s, and interventional radiologists. The patients should be selected for a specific targeted therapy after multidisciplinary consensus. Interventional oncology has established its role in the management of hepatic malignancies. Image-guided locoregional therapies decrease the rate of systemic toxicit作者: 禍害隱伏 時(shí)間: 2025-3-28 23:24
Pathologic Features of Primary and Metastatic Hepatic Malignancies,lial cells, fat storing cells and connective tissue cells. Although neoplasms of hepatocytes are the most common, a significant number of both benign and malignant primary liver neoplasms arising from other cell types can develop, such as tumors of bile duct epithelium (Table?.). In addition, the li作者: 大方不好 時(shí)間: 2025-3-29 03:50 作者: 相同 時(shí)間: 2025-3-29 08:52
Pathologic Features of Primary Colon, Rectal, and Anal Malignancies,r deaths (Colorectal cancer facts & figures?2014–2016, 2014 [.]). Worldwide, colorectal cancer is the fourth leading cause of death and causes almost 700,000 deaths each year (Cancer: fact sheet No. 297, 2015 [.]). This chapter discusses the clinical and pathologic features of the spectrum of epithe作者: 偏離 時(shí)間: 2025-3-29 14:23
Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer,emains controversial, adequate lymph node examination is required for accurate staging such that patients can receive correct adjuvant treatments and for stratification in clinical trials. Nevertheless, wide variation in the quality of lymph node examination exists in the US and many centers are not作者: debble 時(shí)間: 2025-3-29 16:09
Circulating Tumor Cells in Gastrointestinal Cancer: Current Practices and Future Directions,k of adequate biomarkers for screening, diagnosis, staging, and prognosis confounds clinical decision-making and delays potentially effective therapies. Circulating tumor cells (CTCs) are a new biomarker with particular promise in GI cancers, potentially offering clinicians and researchers real-time作者: Angiogenesis 時(shí)間: 2025-3-29 23:44 作者: locus-ceruleus 時(shí)間: 2025-3-30 03:25 作者: resilience 時(shí)間: 2025-3-30 06:33 作者: 淡紫色花 時(shí)間: 2025-3-30 08:40 作者: 獨(dú)裁政府 時(shí)間: 2025-3-30 14:15 作者: 阻止 時(shí)間: 2025-3-30 19:18 作者: Melatonin 時(shí)間: 2025-3-30 23:08 作者: 溫順 時(shí)間: 2025-3-31 02:17 作者: inhumane 時(shí)間: 2025-3-31 06:48
Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer,emains controversial, adequate lymph node examination is required for accurate staging such that patients can receive correct adjuvant treatments and for stratification in clinical trials. Nevertheless, wide variation in the quality of lymph node examination exists in the US and many centers are not meeting guideline treatment recommendations.作者: Macronutrients 時(shí)間: 2025-3-31 11:06 作者: headlong 時(shí)間: 2025-3-31 13:37
https://doi.org/10.1007/978-3-642-59288-1This chapter explores the pathologic features of benign and malignant lesions of the pancreas. As pathologic classifications evolve, particularly for cystic lesions and neuroendocrine tumors, it is important for physicians who treat patients with pancreatic neoplasms to fully evaluate these pathologic classifications.作者: 惡名聲 時(shí)間: 2025-3-31 17:46
Management Controversies and Treatment Strategies for Borderline Resectable Pancreatic Cancer,The management of borderline resectable cancer requires multi-disciplinary care including state-of-the-art radiographic imaging, combination treatment planning with medical oncology and radiation oncology, and technical surgical expertise combining gastrointestinal and vascular surgery.作者: 無(wú)表情 時(shí)間: 2025-4-1 01:22
Pathologic Features of Primary Pancreatic Malignancies,This chapter explores the pathologic features of benign and malignant lesions of the pancreas. As pathologic classifications evolve, particularly for cystic lesions and neuroendocrine tumors, it is important for physicians who treat patients with pancreatic neoplasms to fully evaluate these pathologic classifications.作者: 農(nóng)學(xué) 時(shí)間: 2025-4-1 03:25 作者: 使成波狀 時(shí)間: 2025-4-1 09:24
Gastrointestinal Malignancies978-3-319-34244-3Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: Limousine 時(shí)間: 2025-4-1 12:25
David Bentrem,Al B. BensonAssesses current treatments for the various malignancies of the gastrointestinal tract.Describes the state of the art in radiologic and endoscopic staging.Discusses novel and evolving treatments.Inclu作者: jet-lag 時(shí)間: 2025-4-1 14:54
Continuously Variable Endoscopy,e radical resection was initially the primary treatment for adenocarcinoma of the stomach, systemic chemotherapy and radiation have been shown to play a role in prolonging survival in most patient populations. This chapter explores the evidence that guides treatment for gastric cancer today. It also作者: Vasodilation 時(shí)間: 2025-4-1 19:42 作者: 違法事實(shí) 時(shí)間: 2025-4-2 02:12
Chang-Ming Huang,Chao-Hui Zheng,Jian-Wei Xieise to?neoplasms of neuroendocrine, mesenchymal, and hematolymphoid lineages. Many of these lesions also occur outside of the gastrointestinal tract, such as the extranodal lymphomas and many of the sarcomas, and in many cases share the features of their non-alimentary counterparts. This heterogeneo作者: heirloom 時(shí)間: 2025-4-2 05:48
